Logo image of CLX

CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CLX - US1890541097 - Common Stock

106.19 USD
+1.94 (+1.86%)
Last: 1/9/2026, 8:04:00 PM
106.08 USD
-0.11 (-0.1%)
After Hours: 1/9/2026, 8:04:00 PM
Fundamental Rating

4

Overall CLX gets a fundamental rating of 4 out of 10. We evaluated CLX against 12 industry peers in the Household Products industry. There are concerns on the financial health of CLX while its profitability can be described as average. CLX has a expensive valuation and it also scores bad on growth. CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CLX was profitable.
CLX had a positive operating cash flow in the past year.
In the past 5 years CLX has always been profitable.
CLX had a positive operating cash flow in each of the past 5 years.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

CLX has a better Return On Assets (14.31%) than 83.33% of its industry peers.
The Return On Invested Capital of CLX (21.90%) is better than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLX is above the industry average of 14.87%.
The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

CLX's Profit Margin of 11.68% is fine compared to the rest of the industry. CLX outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of CLX has declined.
With a Operating Margin value of 15.17%, CLX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
CLX's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 44.28%, CLX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CLX has remained more or less at the same level.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

CLX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CLX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLX has less shares outstanding
CLX has a worse debt/assets ratio than last year.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.17 indicates that CLX is not in any danger for bankruptcy at the moment.
CLX has a Altman-Z score of 3.17. This is comparable to the rest of the industry: CLX outperforms 50.00% of its industry peers.
CLX has a debt to FCF ratio of 4.25. This is a neutral value as CLX would need 4.25 years to pay back of all of its debts.
CLX has a worse Debt to FCF ratio (4.25) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.17
ROIC/WACC2.79
WACC7.85%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.76 indicates that CLX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.76, CLX is doing worse than 83.33% of the companies in the same industry.
CLX has a Quick Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLX (0.50) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

CLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.99%.
Measured over the past 5 years, CLX shows a small growth in Earnings Per Share. The EPS has been growing by 1.01% on average per year.
CLX shows a decrease in Revenue. In the last year, the revenue decreased by -9.35%.
The Revenue has been growing slightly by 1.11% on average over the past years.
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%

3.2 Future

The Earnings Per Share is expected to grow by 1.36% on average over the next years.
CLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.10% yearly.
EPS Next Y-22.5%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
EPS Next 5Y1.36%
Revenue Next Year-7.88%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.80 indicates a correct valuation of CLX.
The rest of the industry has a similar Price/Earnings ratio as CLX.
CLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.19.
With a Price/Forward Earnings ratio of 15.56, CLX is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as CLX.
CLX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.8
Fwd PE 15.56
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLX is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLX indicates a slightly more expensive valuation: CLX is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.37
EV/EBITDA 12.24
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The decent profitability rating of CLX may justify a higher PE ratio.
CLX's earnings are expected to decrease with -2.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)15.6
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.76%, CLX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.75, CLX pays a better dividend. On top of this CLX pays more dividend than 83.33% of the companies listed in the same industry.
CLX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 4.76%

5.2 History

The dividend of CLX has a limited annual growth rate of 2.88%.
CLX has paid a dividend for at least 10 years, which is a reliable track record.
CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

76.11% of the earnings are spent on dividend by CLX. This is not a sustainable payout ratio.
CLX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (1/9/2026, 8:04:00 PM)

After market: 106.08 -0.11 (-0.1%)

106.19

+1.94 (+1.86%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)01-29 2026-01-29/amc
Inst Owners89.77%
Inst Owner Change0.21%
Ins Owners0.4%
Ins Owner Change13.39%
Market Cap12.95B
Revenue(TTM)6.77B
Net Income(TTM)791.00M
Analysts54.81
Price Target125.4 (18.09%)
Short Float %5.81%
Short Ratio3.13
Dividend
Industry RankSector Rank
Dividend Yield 4.76%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-28 2026-01-28 (1.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-4.45%
PT rev (3m)-10.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.61%
EPS NY rev (1m)0.07%
EPS NY rev (3m)-2.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 15.8
Fwd PE 15.56
P/S 1.91
P/FCF 20.37
P/OCF 15.19
P/B N/A
P/tB N/A
EV/EBITDA 12.24
EPS(TTM)6.72
EY6.33%
EPS(NY)6.82
Fwd EY6.43%
FCF(TTM)5.21
FCFY4.91%
OCF(TTM)6.99
OCFY6.59%
SpS55.51
BVpS-0.18
TBVpS-14.84
PEG (NY)N/A
PEG (5Y)15.6
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.17
F-Score6
WACC7.85%
ROIC/WACC2.79
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
EPS Next Y-22.5%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
EPS Next 5Y1.36%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%
Revenue Next Year-7.88%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.1%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year5.87%
EBIT Next 3Y7.02%
EBIT Next 5Y6.13%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 4 / 10 to CLX.


What is the valuation status for CLX stock?

ChartMill assigns a valuation rating of 4 / 10 to CLOROX COMPANY (CLX). This can be considered as Fairly Valued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CLOROX COMPANY (CLX) stock?

The Price/Earnings (PE) ratio for CLOROX COMPANY (CLX) is 15.8 and the Price/Book (PB) ratio is -588.78.


How sustainable is the dividend of CLOROX COMPANY (CLX) stock?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 76.11%.